EEUU seguirá teniendo acceso a datos bancarios de los europeos

BRUSELAS (AFP) – Los países de la Unión Europea (UE) decidieron mantener vigente por nueve meses el acceso de Estados Unidos a los datos bancarios de ciudadanos europeos, tras haber superado las reticencias de Alemania y Austria, indicó este lunes una fuente diplomática.

The KR 16will be executing dry tool paths of the waterjet process around complex 3D partswith quick change tooling ability to demonstrate milling, drilling, and materialhandling. The quick tool changing function uses KUKA`s hand teach device,allowing for automatic tool change function and enabling the user to teach atool path manually using a joystick while utilizing KUKA safe robot technology.The KR16 robotic cell demonstration was designed and supplied by FlowInternational Corporation. In a robotic cell designed and supplied by Official KUKA Robotics SystemPartner, Dyco Inc. the flexible, fast handling KR5 Sixx will be demonstratedutilizing a vision system. The vision system enables the KR5 Sixx to locate andpick random plastic bottles from a moving conveyor belt simulating loading puckcarriers. This same solution could be used for material handling to pick randombottles and load cases.

KUKA Robotics will also display a KR5 Arc in a demo cell designed and suppliedby Electro-Hydraulic Automation an Official KUKA Robotics System Partner. Thedemo cell shows the highly versatile KR5 ARC holding an air powered cutting toolto trim and cut holes in plastics parts, simulating the cuts used in vehicledashboard openings. KUKA Robotics will display an injection molding extraction cell using the KR5Sixx. The KR5 Sixx features the flexibility of variable mounting options offloor or ceiling along with fast handling capabilities, will simulate theextraction of medical syringes from an injection molding machine. The KUKA Robotics System Partner network is designed to mutually benefit eachorganization`s users by extending the way customers can access tailoredsolutions from experienced system partners with the major competitive andtechnological advantage of high precision KUKA robots.

The KUKA Robotics SystemPartner Network includes experienced system builders, system providers,application specialists and expert robot integrators. KUKA robots are utilized in many different facets of the robotics industry fromautomotive, aerospace, consumer goods, logistics, food, pharmaceutical, medical,foundry and plastics industries and in multiple applications including materialhandling, packaging, palletizing, welding and surface finishing. For moreinformation contact KUKA Robotics at 866-873-5852 or visit their website at. About the KUKA Robot GroupKUKA Roboter GmbH, Augsburg, is a member of the KUKA Aktiengesellschaft andranks among the world`s leading suppliers of industrial robots.

Corecompetencies are the development, production and sale of industrial robots,controllers, software and linear units. The company is the market leader inGermany and Europe, and the number three in the world The KUKA Robot Groupemploys about 2,200 people worldwide. Of these, 1,200 are employed in Germany,either at the KUKA Robot Group headquarters in Augsburg, or at varioussubsidiaries In 2008, sales totaled 474 million euro. Twenty-six subsidiariesprovide a presence in the major markets of Europe, America and Asia.The KUKA logo is a registered trademark of KUKA Roboter GmbH KUKA, is atrademark of KUKA Roboter GmbH. All other trademarks are owned by theirrespective companies.KUKA Robotics CorporationMedia ContactRebecca MarkelMarketing ManagerPhone: Business Wire 2009. (Recasts on order against Google) Stocks  |  Media  |  China BEIJING, June 19 (Reuters) – China’s Internet watchdog onFriday ordered Google (GOOG.O) to stop overseas websites with”pornographic and vulgar” content from being accessed throughits Chinese-language search engine.

KABUL (AFP) – El gobierno afgano anunció este lunes en Kabul la creación de una unidad policial especializada en la lucha contra la corrupción, después de intensas presiones de la comunidad internacional para poner fin a ese problema endémico, incluso en los niveles más altos del Estado.

The KR 16will be executing dry tool paths of the waterjet process around complex 3D partswith quick change tooling ability to demonstrate milling, drilling, and materialhandling. The quick tool changing function uses KUKA`s hand teach device,allowing for automatic tool change function and enabling the user to teach atool path manually using a joystick while utilizing KUKA safe robot technology.The KR16 robotic cell demonstration was designed and supplied by FlowInternational Corporation. In a robotic cell designed and supplied by Official KUKA Robotics SystemPartner, Dyco Inc. the flexible, fast handling KR5 Sixx will be demonstratedutilizing a vision system. The vision system enables the KR5 Sixx to locate andpick random plastic bottles from a moving conveyor belt simulating loading puckcarriers. This same solution could be used for material handling to pick randombottles and load cases. KUKA Robotics will also display a KR5 Arc in a demo cell designed and suppliedby Electro-Hydraulic Automation an Official KUKA Robotics System Partner.

Thedemo cell shows the highly versatile KR5 ARC holding an air powered cutting toolto trim and cut holes in plastics parts, simulating the cuts used in vehicledashboard openings. KUKA Robotics will display an injection molding extraction cell using the KR5Sixx. The KR5 Sixx features the flexibility of variable mounting options offloor or ceiling along with fast handling capabilities, will simulate theextraction of medical syringes from an injection molding machine. The KUKA Robotics System Partner network is designed to mutually benefit eachorganization`s users by extending the way customers can access tailoredsolutions from experienced system partners with the major competitive andtechnological advantage of high precision KUKA robots. The KUKA Robotics SystemPartner Network includes experienced system builders, system providers,application specialists and expert robot integrators. KUKA robots are utilized in many different facets of the robotics industry fromautomotive, aerospace, consumer goods, logistics, food, pharmaceutical, medical,foundry and plastics industries and in multiple applications including materialhandling, packaging, palletizing, welding and surface finishing.

For moreinformation contact KUKA Robotics at 866-873-5852 or visit their website at. About the KUKA Robot GroupKUKA Roboter GmbH, Augsburg, is a member of the KUKA Aktiengesellschaft andranks among the world`s leading suppliers of industrial robots. Corecompetencies are the development, production and sale of industrial robots,controllers, software and linear units. The company is the market leader inGermany and Europe, and the number three in the world The KUKA Robot Groupemploys about 2,200 people worldwide. Of these, 1,200 are employed in Germany,either at the KUKA Robot Group headquarters in Augsburg, or at varioussubsidiaries In 2008, sales totaled 474 million euro. Twenty-six subsidiariesprovide a presence in the major markets of Europe, America and Asia.The KUKA logo is a registered trademark of KUKA Roboter GmbH KUKA, is atrademark of KUKA Roboter GmbH. All other trademarks are owned by theirrespective companies.KUKA Robotics CorporationMedia ContactRebecca MarkelMarketing ManagerPhone: Business Wire 2009.

PARÍS (AFP) – El equipo ciclista Caisse d’Epargne se retirará del Tour de Francia tras la edición de la prueba de 2010, anunció este viernes en una radio gala François Perol, presidente del grupo bancario Banque Populaire-Caisses d’Epargne (BPCE)

(NASDAQ:AEZS; TSX: AEZ), a global biopharmaceutical company focused on endocrinetherapy and oncology, announced today that it has received commitments topurchase US$10 million of units comprised of common shares and common sharepurchase warrants in a registered direct offering. AEterna Zentaris expects toreceive net proceeds of approximately US$9.25 million after deductingplacement agent fees and other offering expenses. Under the terms of aSecurities Purchase Agreement, the Company will sell to such institutionalinvestors an aggregate of 5,319,149 common shares of its capital at a price ofUS$1.88 per share and issue warrants to acquire an aggregate of 1,861,702common shares at an exercise price of US$2.06 per share.The warrants to purchase additional common shares of AEterna Zentaris will beexercisable beginning three months after issuance and will expire 30 monthsafter issuance. All of the common shares and warrants were offered pursuant toan effective shelf registration statement. Proceeds from the transaction willbe used for general corporate purposes, including clinical development of ourleading oncology and endocrinology compounds.

The offering is expected to beconsummated no later than June 24, 2009, subject to customary closingconditions.Rodman & Renshaw, LLC, a subsidiary of Rodman & Renshaw Capital Group, Inc.,(Nasdaq: RODM ( )), acted as the exclusiveplacement agent for the transaction. The placement agent will receivethirty-month warrants, exercisable beginning six months after issuance, topurchase 287,234 common shares at US$2.35 per share.In connection with the offering, the Company will file a prospectus supplementto its existing base shelf prospectus with the Canadian securities regulatoryauthorities and with the Securities and Exchange Commission. Copies of theprospectus supplement and accompanying prospectus may be obtained directlyfrom the Company or by contacting AEterna Zentaris Inc., 1405 duParc-Technologique Boulevard, Quebec City, Canada G1P 4P5.This press release shall not constitute an offer to sell or a solicitation ofan offer to buy any securities nor shall there be any sale of such securitiesin any jurisdiction in which such offer, solicitation or sale would beunlawful prior to registration or qualification under the securities laws ofany such jurisdiction. This offering is being made by means of a prospectussupplement to the Company’s existing base prospectus that is part of its shelfregistration statement previously filed with and declared effective by theSecurities and Exchange Commission.About AEterna Zentaris Inc.AEterna Zentaris Inc. is a global biopharmaceutical company focused onendocrine therapy and oncology, with proven expertise in drug discovery,development and commercialization. News releases and additional informationare available at StatementsThis press release contains forward-looking statements made pursuant to thesafe harbor provisions of the U.S.

Securities Litigation Reform Act of 1995.Forward-looking statements involve known and unknown risks and uncertainties,which could cause the Company’s actual results to differ materially from thosein the forward-looking statements. Such risks and uncertainties include, amongothers, the availability of funds and resources to pursue R&D projects, thesuccessful and timely completion of clinical studies, the ability of theCompany to take advantage of business opportunities in the pharmaceuticalindustry, uncertainties related to the regulatory process and general changesin economic conditions. Investors should consult the Company’s quarterly andannual filings with the Canadian and U.S. securities commissions foradditional information on risks and uncertainties relating to theforward-looking statements. Investors are cautioned not to rely on theseforward-looking statements.

LONDRES (AFP) – La norteamericana Kathryn Bigelow obtuvo el premio a la mejor película, por “The Hurt Locker”, la noche de este domingo en la ceremonia de los premios Bafta, las preseas británicas del cine, derrotando a su ex marido, James Cameron, que competía con “Avatar”.

The industrialend-user segment is also emerging as a significant source of retrofits, as plantowners have been investing in capacity expansions, new expansions, andrefurbishing aging power generation plants to improve productivity. Industrieshad invested substantially in brown field projects and maintenance and capacityreplacement in 2007, providing relief to gasket manufacturers. Although the economic slump is likely to defer a few industrial projects thatwere to be taken up in 2009 and 2010, the already initiated ones will go a longway in shoring up the gaskets market. The postponement of oil and gas expansionprojects will also curb the rapid growth of the market until 2010. “Decreasingoil prices are expected to reduce capacities until 2010, but with marketstabilization, the refurbishment of existing plants becomes necessary,” says theanalyst of this research. “The aftermarket business will see the gaskets marketsgrow moderately during this period.” Acknowledging the challenge of operating inthese difficult economic environments, companies all over the world are strivingto lower operational expenditure and improve returns on investment.

With manycompanies also looking to considerably downsize maintenance personnel forequipment repair or breakdown, there is a large market for products that offerbetter reliability and life cycle cost benefits. DUBLIN–(Business Wire)–Research and Markets( http://) hasannounced the addition of the “Three Case Studies in Technology Innovation(Apple, Google, Pixar)” report to their offering. This bundled report contains three innovation case studies, and focus on theinnovation efforts of Apple, Google, and Pixar. These three companies haveconsistently defined the cutting-edge in technology. In the Apple case study, learn how the company has re-emerged as one of theworld’s most innovative companies. Apple has managed to sustain its innovationefforts with calculated, consistent increases in R&D spending and rapid-firelaunches of new products and upgrades. Learn how Apple’s success has beenbecause the company has deliberately focused its efforts on generating betterideas faster.

MADRID (AFP) – El Valencia, que se impuso con facilidad este domingo en terreno del colista Xerez por 3-1, en la 17ª jornada de la liga española de fútbol, consolidó su tercera plaza y se acercó a los dos primeros, Barcelona y Real Madrid, que jugaban más tarde.

(NASDAQ:AEZS; TSX: AEZ), a global biopharmaceutical company focused on endocrinetherapy and oncology, announced today that it has received commitments topurchase US$10 million of units comprised of common shares and common sharepurchase warrants in a registered direct offering. AEterna Zentaris expects toreceive net proceeds of approximately US$9.25 million after deductingplacement agent fees and other offering expenses. Under the terms of aSecurities Purchase Agreement, the Company will sell to such institutionalinvestors an aggregate of 5,319,149 common shares of its capital at a price ofUS$1.88 per share and issue warrants to acquire an aggregate of 1,861,702common shares at an exercise price of US$2.06 per share.The warrants to purchase additional common shares of AEterna Zentaris will beexercisable beginning three months after issuance and will expire 30 monthsafter issuance. All of the common shares and warrants were offered pursuant toan effective shelf registration statement. Proceeds from the transaction willbe used for general corporate purposes, including clinical development of ourleading oncology and endocrinology compounds. The offering is expected to beconsummated no later than June 24, 2009, subject to customary closingconditions.Rodman & Renshaw, LLC, a subsidiary of Rodman & Renshaw Capital Group, Inc.,(Nasdaq: RODM ( )), acted as the exclusiveplacement agent for the transaction. The placement agent will receivethirty-month warrants, exercisable beginning six months after issuance, topurchase 287,234 common shares at US$2.35 per share.In connection with the offering, the Company will file a prospectus supplementto its existing base shelf prospectus with the Canadian securities regulatoryauthorities and with the Securities and Exchange Commission.

Copies of theprospectus supplement and accompanying prospectus may be obtained directlyfrom the Company or by contacting AEterna Zentaris Inc., 1405 duParc-Technologique Boulevard, Quebec City, Canada G1P 4P5.This press release shall not constitute an offer to sell or a solicitation ofan offer to buy any securities nor shall there be any sale of such securitiesin any jurisdiction in which such offer, solicitation or sale would beunlawful prior to registration or qualification under the securities laws ofany such jurisdiction. This offering is being made by means of a prospectussupplement to the Company’s existing base prospectus that is part of its shelfregistration statement previously filed with and declared effective by theSecurities and Exchange Commission.About AEterna Zentaris Inc.AEterna Zentaris Inc. is a global biopharmaceutical company focused onendocrine therapy and oncology, with proven expertise in drug discovery,development and commercialization. News releases and additional informationare available at StatementsThis press release contains forward-looking statements made pursuant to thesafe harbor provisions of the U.S. Securities Litigation Reform Act of 1995.Forward-looking statements involve known and unknown risks and uncertainties,which could cause the Company’s actual results to differ materially from thosein the forward-looking statements. Such risks and uncertainties include, amongothers, the availability of funds and resources to pursue R&D projects, thesuccessful and timely completion of clinical studies, the ability of theCompany to take advantage of business opportunities in the pharmaceuticalindustry, uncertainties related to the regulatory process and general changesin economic conditions.

Investors should consult the Company’s quarterly andannual filings with the Canadian and U.S. securities commissions foradditional information on risks and uncertainties relating to theforward-looking statements. Investors are cautioned not to rely on theseforward-looking statements. The Company does not undertake to update theseforward-looking statements. We disclaim any obligation to update any suchfactors or to publicly announce the result of any revisions to any of theforward-looking statements contained herein to reflect future results, eventsor developments except if we are requested by a governmental authority orapplicable law.SOURCEAETERNA ZENTARIS INC.Investor Relations: Ginette Vallieres, Investor Relations Coordinator, (418)652-8525 ext. 265, ; Media Relations: Paul Burroughs,Director of Communications, (418) 652-8525 ext. 406, .

FREDERICK, MD, Jun 19 (MARKET WIRE) — BioElectronics Corp. (PINKSHEETS: BIEL), the maker of inexpensive,disposable drug-free anti-inflammatory devices, today provided itsinvestors with a summary of the conference call held after the marketclosed on Thursday, June 18th. On the conference call, the managementteam discussed the numerous ongoing clinical trials, expected FDAsubmissions and the Company’s marketing plans through the end of theyear. Because attendance in the call was significantly more than expectedwith more than 575 investors attempting to access to the call, whichoverwhelm the conference calling system, the Company is providing thefollowing summary for those investors who were unable to participate.The major emphasis of the call was the numerous clinical trials currentlyunderway, several of which are completing the final stages. These clinicaltrials will be used as the basis for additional applications to the FDAfor 510(k) marketing clearance.”We want to thank everyone for their overwhelming level of enthusiasmrelative to our recent corporate progress. Our near-term objective is toreceive FDA clearance to market our products over the counter in thedrugstore and grocery store chains within the United States, commentedAndrew Whelan, CEO of BioElectronics Corp.

MIAMI (AFP) – La ola de frío polar en Estados Unidos, que alcanzó a Florida (sureste del país) con nevadas en los últimos días y temperaturas mínimas récord en enero, está provocando la muerte y blanqueamiento de los sistemas de corales que habitan aguas usualmente cálidas de la península y los cayos, según los expertos.

The FDA staff memo was released ahead of an advisory panelmeeting, scheduled for Tuesday, where outside experts willreview the safety of various drugs for children. Depakote was once a blockbuster for Abbott but salesdropped sharply after generic competitors became available.First-quarter sales for the drug were $110 million. “For many women, Depakote may be the only effectivemedicine to control their seizures” and doctors and patientsshould evaluate the drug’s risks versus its benefits, Powerssaid. At the same time webelieve that SanJiang will facilitate our ability to get all relatedlogistics in place and to obtain further land assets as needed.”ABOUT SANJIANG AGRICULTURE CO LTD.SanJiang Agriculture Co Ltd. We will provide thetechnology, know-how and management of the operation. Under the Joint Venture,SanJiang will provide the land and factory buildings. Credit Agricole was also told by the antitrust not to take arole in corporate governance at Intesa Sanpaolo but under itsoriginal pact with Generali it did.

The two suspended their original agreement until June 30 andare putting together a revised pact which they hope will satisfyantitrust authorities. TOUGH MEASURES? The source said on Friday that if the antitrust authorityreceived a formal request for an extension of the deadline tosell, it was likely to accept but impose restrictions on thestake. The authority granted an extension to Italy’s biggest bank,UniCredit (CRDI.MI) on selling 3.24 percent of Generali lastyear with the condition of suspending voting rights. Intesa Sanpaolo could face a fine of up to 5 billion eurosfrom the antitrust, newspapers have reported, for failing toensure shareholders meet its requirements. On Friday, Intesa Sanpaolo’s chief executive, CorradoPassera, said its shareholders would find a solution if the bankfaced a fine. “Shareholders will find a solution which won’t createproblems for the bank,” Passera said on the sidelines of aconference in Milan He gave no further details. One analyst suggested Intesa Sanpaolo might try to share thepossible fine with Credit Agricole and Generali.

Passera also confirmed the bank would soon take advantage ofgovernment-backed bonds aimed at boosting Italian banks’capital. Intesa shares were down 3.1 percent at 2.265 euros by 1422GMT while Credit Agricole was broadly flat The DJ Stoxx indexof banks .SX7P was up 0.91 percent (writing by Jo Winterbottom, Editing by Andy Bruce) Italy. CINCINNATI–(Business Wire)–Starbucks Corporation (NASDAQ: SBUX) attracted a slew of put traders onThursday, after the java giant recalled more than half a million coffeegrinders. According to data from WhatsTrading , the equity saw nearly 8,750puts cross the tape yesterday, more than doubling its average single-sessionvolume of roughly 4,000 contracts.

Most active was the July 14 put, which saw about 5,700 contracts change handsyesterday. The at-the-money option – which assumes front-month status after theclosing bell today – saw open interest climb from 5,948 to 10,932 overnight,suggesting most of the activity was of the buy-to-open variety. What’s more, theSBUX July 14 put remains popular today, with nearly 1,800 contracts exchangedwithin the first hour of trading. To continue reading this article, click here: http://’s Investment ResearchAndrea Kramer, Copyright Business Wire 2009. NEW YORK–(Business Wire)–Ambac Financial Group, Inc. (NYSE: ABK) (“Ambac” or the “Company”) todayannounced that it has postponed its efforts to launch Everspan FinancialGuarantee Corp (Everspan).

NUEVO LAREDO, México (AFP) – Diez hombres murieron el domigo, cinco de ellos acribillados en un bar, en hechos relacionados con el crimen organizado en el estado mexicano de Tamaulipas (al noreste), fronterizo con Estados Unidos, informaron autoridades locales.

NEW YORK–(Business Wire)–Fitch Ratings has updated its U.S. CMBS servicer rating criteria to reflectcurrent commercial real estate (CRE) market conditions and their effect onmortgage servicing. These changes have resulted in moderate rating movement(both upgrades and downgrades) for certain servicers, as detailed in severalpress releases also published today. The three main changes to the existing criteria are as follows: –The first change addresses the servicer’s financial rating. Fitch hasincreased its financial weightings for both master and special servicer ratingsto better reflect its significance; –The second relates to employee experience. Fitch increased its scoring hurdlesin management and staff experience to reflect this view; –Finally, due to the increased complexity of recent vintage CMBS servicing,Fitch has increased emphasis on the servicer’s participation in the CMBS marketover the past few years.

Additional information about Fitch’s updated commercial mortgage servicercriteria is available in a full report also released today (‘U.S. CommercialMortgage Servicer Rating Criteria’) which is available at the following headers: Structured Finance >> Operational Risk Group >> Criteria Reports >> CMBS In conjunction with the rollout of the new servicer criteria, Fitch upgraded anddowngraded 16 ratings across 12 companies. Upgrades were made for the followingcompanies: –CWCapital LLC (primary and master servicer); –CWCapital Asset Management LLC (special servicer); –The Bank of New York Mellon – Asset Solutions Division (primary and masterservicer) Downgrades were taken on: –Archon Group, L.P (special servicer); –Centerline Servicing Inc. (special servicer); –CT Investment Management Co., LLC (special servicer); –Hudson Advisors, LLC (special servicer); –J.E Robert Companies (special servicer); –LNR Partners, Inc. (special servicer); –NCB, FSB (primary servicer); –Ocwen Loan Servicing, LLC (special servicer); –Wachovia Securities (primary servicer); –Wells Fargo Bank (primary and special servicer). Additionally, Fitch has affirmed all of the servicer ratings for the followingcompanies: –Babson Capital Management, LLC; –Bank of America, N.A.; –DB Mortgage Services, LLC; –GE Capital Realty Group; –GEMSA Loan Services, L.P.; –Helios AMC, LLC; –ING Clarion Capital Loan Services, LLC; –KeyBank Real Estate Capital; –Midland Loan Services; –National Cooperative Bank; –ORIX Capital Markets, LLC; –Pacific Life Insurance Company; –Protective Life Insurance Company; –Prudential Asset Resources; –Situs Asset Management; –TriMont Real Estate Advisors, Inc. All individual rating action press releases are available at A detailed list of all Fitch U.S.

MADRID (AFP) – El alemán Linus Gerdemann (Milram) ganó este martes el Trofeo Inca, tercera prueba ciclista de la XIX Challenge a Mallorca, que se disputó desde la localidad de Inca a lo largo de 157,2 km.

Shares in PKN rose 2.2 percent late in the session, in linewith the wider market. The stock has gained 9.4 percent so farthis year, outperforming a 7.7 percent rise of Warsaw’s mainWIG20 index .WIG20 (Editing by David Jones). BEIJING, June 19 /PRNewswire-Asia/ — Sinovac Biotech Ltd.(NYSE Amex: SVA), a leading developer and provider of vaccines in China,announced today that the Company received the first order in China to supplyits influenza A (H1N1) vaccine to the Beijing government. The initial orderconsists of 4 million doses and is expected to be delivered by the end ofSeptember.This order will be administered to 2 million people in the highrisk group.Additional orders are expected beginning in October and, intotal,Sinovac expects to supply approximately 10 million doses to the Beijinggovernment.The 10 million doses will be administered to 5 million people inBeijing.On June 14, 2009, Sinovac completed construction of the H1N1 virus seedbank necessary to produce a virus antigen and commenced production of thefirst batch of H1N1 vaccine.Sinovac expects to complete production of thefirst batch by the end of July.Mr. Weidong Yin, Chairman, President and CEO of Sinovac, commented, “Weare organizing and coordinating all personnel and resources to produce theH1N1 vaccine, as we have almost completed the production of our seasonalinfluenza vaccine.With the support and instruction of the relevantgovernment and health authorities, Sinovac will fully utilize its provendevelopment and production abilities from both the H5N1 vaccine and seasonalflu vaccine to ensure the efficient production of the H1N1 vaccine.We areworking closely with authorities in order to contribute to the prevention andcontrol of the H1N1 epidemic situation.”About SinovacSinovac Biotech Ltd. is a China-based biopharmaceutical company thatfocuses on the research, development, manufacture and commercialization ofvaccines that protect against human infectious diseases. Sinovac’s vaccineproducts include Healive(R) (hepatitis A), Bilive(R) (combined hepatitis A andB), and Anflu(R) (influenza).

Panflu(TM), Sinovac’s pandemic influenza vaccine(H5N1), has already been approved for government stockpiling.Sinovac isdeveloping vaccines for enterovirus 71, universal pandemic influenza, Japaneseencephalitis vaccine, and human rabies vaccine.Its wholly owned subsidiary,Tangshan Yian, is conducting field trials for independently developedinactivated animal rabies vaccines.Safe Harbor StatementThis announcement contains forward-looking statements. These statementsare made under the “safe harbor” provisions of the U.S Private SecuritiesLitigation Reform Act of 1995. These forward-looking statements can beidentified by words or phrases such as “will,” “expects,” “anticipates,”"future,” “intends,” “plans,” “believes,” “estimates” and similar statements.Among other things, the business outlook and quotations from management inthis press release contain forward-looking statements. Statements that are nothistorical facts, including statements about Sinovac’s beliefs andexpectations, are forward-looking statements. Forward-looking statementsinvolve inherent risks and uncertainties. A number of important factors couldcause actual results to differ materially from those contained in anyforward-looking statement. Sinovac does not undertake any obligation to updateany forward-looking statement, except as required under applicable law.For more information, please contact: Helen G Yang Sinovac Biotech Ltd.

SOFÍA (AFP) – El fisco búlgaro abrió una investigación por fraude que alcanza a 261 futbolistas profesionales, más o menos la mitad de los que militan en la primera división local, anunció este martes.

The KR 16will be executing dry tool paths of the waterjet process around complex 3D partswith quick change tooling ability to demonstrate milling, drilling, and materialhandling. The quick tool changing function uses KUKA`s hand teach device,allowing for automatic tool change function and enabling the user to teach atool path manually using a joystick while utilizing KUKA safe robot technology.The KR16 robotic cell demonstration was designed and supplied by FlowInternational Corporation. In a robotic cell designed and supplied by Official KUKA Robotics SystemPartner, Dyco Inc. the flexible, fast handling KR5 Sixx will be demonstratedutilizing a vision system. The vision system enables the KR5 Sixx to locate andpick random plastic bottles from a moving conveyor belt simulating loading puckcarriers.

This same solution could be used for material handling to pick randombottles and load cases. KUKA Robotics will also display a KR5 Arc in a demo cell designed and suppliedby Electro-Hydraulic Automation an Official KUKA Robotics System Partner. Thedemo cell shows the highly versatile KR5 ARC holding an air powered cutting toolto trim and cut holes in plastics parts, simulating the cuts used in vehicledashboard openings. KUKA Robotics will display an injection molding extraction cell using the KR5Sixx. The KR5 Sixx features the flexibility of variable mounting options offloor or ceiling along with fast handling capabilities, will simulate theextraction of medical syringes from an injection molding machine. The KUKA Robotics System Partner network is designed to mutually benefit eachorganization`s users by extending the way customers can access tailoredsolutions from experienced system partners with the major competitive andtechnological advantage of high precision KUKA robots.

VANCOUVER, Canadá (AFP) – El noruego Ole Einar Bjorndalen entró en la historia con su sexta medalla de oro y undécima en total en Juegos Olímpicos de Invierno, en una jornada del viernes que vio desdibujarse a la estrella estadounidense Lindsey Vonn y a las esquiadoras latinoamericanas seguir en la porfía del esquí alpino.

The industrialend-user segment is also emerging as a significant source of retrofits, as plantowners have been investing in capacity expansions, new expansions, andrefurbishing aging power generation plants to improve productivity. Industrieshad invested substantially in brown field projects and maintenance and capacityreplacement in 2007, providing relief to gasket manufacturers. Although the economic slump is likely to defer a few industrial projects thatwere to be taken up in 2009 and 2010, the already initiated ones will go a longway in shoring up the gaskets market. The postponement of oil and gas expansionprojects will also curb the rapid growth of the market until 2010. “Decreasingoil prices are expected to reduce capacities until 2010, but with marketstabilization, the refurbishment of existing plants becomes necessary,” says theanalyst of this research.

“The aftermarket business will see the gaskets marketsgrow moderately during this period.” Acknowledging the challenge of operating inthese difficult economic environments, companies all over the world are strivingto lower operational expenditure and improve returns on investment. With manycompanies also looking to considerably downsize maintenance personnel forequipment repair or breakdown, there is a large market for products that offerbetter reliability and life cycle cost benefits. DUBLIN–(Business Wire)–Research and Markets( http://) hasannounced the addition of the “Three Case Studies in Technology Innovation(Apple, Google, Pixar)” report to their offering. This bundled report contains three innovation case studies, and focus on theinnovation efforts of Apple, Google, and Pixar. These three companies haveconsistently defined the cutting-edge in technology.

CIUDAD DEL VATICANO (AFP) – Las iglesias abandonadas por los fieles y sin valor artístico podrán ser demolidas o vendidas pero no pueden ser transformadas en discotecas, anunció este jueves el ministro de Cultura del Vaticano, monseñor Gianfranco Ravasi.

The KR 16will be executing dry tool paths of the waterjet process around complex 3D partswith quick change tooling ability to demonstrate milling, drilling, and materialhandling. The quick tool changing function uses KUKA`s hand teach device,allowing for automatic tool change function and enabling the user to teach atool path manually using a joystick while utilizing KUKA safe robot technology.The KR16 robotic cell demonstration was designed and supplied by FlowInternational Corporation. In a robotic cell designed and supplied by Official KUKA Robotics SystemPartner, Dyco Inc. the flexible, fast handling KR5 Sixx will be demonstratedutilizing a vision system. The vision system enables the KR5 Sixx to locate andpick random plastic bottles from a moving conveyor belt simulating loading puckcarriers. This same solution could be used for material handling to pick randombottles and load cases. KUKA Robotics will also display a KR5 Arc in a demo cell designed and suppliedby Electro-Hydraulic Automation an Official KUKA Robotics System Partner.

Thedemo cell shows the highly versatile KR5 ARC holding an air powered cutting toolto trim and cut holes in plastics parts, simulating the cuts used in vehicledashboard openings. KUKA Robotics will display an injection molding extraction cell using the KR5Sixx. The KR5 Sixx features the flexibility of variable mounting options offloor or ceiling along with fast handling capabilities, will simulate theextraction of medical syringes from an injection molding machine. The KUKA Robotics System Partner network is designed to mutually benefit eachorganization`s users by extending the way customers can access tailoredsolutions from experienced system partners with the major competitive andtechnological advantage of high precision KUKA robots. The KUKA Robotics SystemPartner Network includes experienced system builders, system providers,application specialists and expert robot integrators. KUKA robots are utilized in many different facets of the robotics industry fromautomotive, aerospace, consumer goods, logistics, food, pharmaceutical, medical,foundry and plastics industries and in multiple applications including materialhandling, packaging, palletizing, welding and surface finishing.

For moreinformation contact KUKA Robotics at 866-873-5852 or visit their website at. About the KUKA Robot GroupKUKA Roboter GmbH, Augsburg, is a member of the KUKA Aktiengesellschaft andranks among the world`s leading suppliers of industrial robots. Corecompetencies are the development, production and sale of industrial robots,controllers, software and linear units. The company is the market leader inGermany and Europe, and the number three in the world The KUKA Robot Groupemploys about 2,200 people worldwide. Of these, 1,200 are employed in Germany,either at the KUKA Robot Group headquarters in Augsburg, or at varioussubsidiaries In 2008, sales totaled 474 million euro. Twenty-six subsidiariesprovide a presence in the major markets of Europe, America and Asia.The KUKA logo is a registered trademark of KUKA Roboter GmbH KUKA, is atrademark of KUKA Roboter GmbH.

All other trademarks are owned by theirrespective companies.KUKA Robotics CorporationMedia ContactRebecca MarkelMarketing ManagerPhone: Business Wire 2009. (Recasts on order against Google) Stocks  |  Media  |  China BEIJING, June 19 (Reuters) – China’s Internet watchdog onFriday ordered Google (GOOG.O) to stop overseas websites with”pornographic and vulgar” content from being accessed throughits Chinese-language search engine. The China Internet Illegal Information Reporting Centre hadtold Google to “make immediate changes” and clean up thecontent available through its search engine (),the official Xinhua news agency reported. The targetting of Google illustrates the difficulties facedby foreign Internet firms doing business in the world’s largestonline market while avoiding charges of censorship. In an emailed statement, Google said it met with governmentofficials to discuss the problem of “pornographic content andmaterial that is harmful to children on the web in China”. “We are undertaking a thorough review of our service andtaking all necessary steps to fix any problems with ourresults.

WASHINGTON (AFP) – El presidente Barack Obama ordenó reforzar la seguridad en los vuelos en Estados Unidos, tras el incidente causado por un hombre que intentó encender un explosivo a bordo de un avión que aterrizó en Detroit y quien admitió sus vínculos con la red islamista Al Qaida, según los medios estadounidenses.

(NASDAQ:AEZS; TSX: AEZ), a global biopharmaceutical company focused on endocrinetherapy and oncology, announced today that it has received commitments topurchase US$10 million of units comprised of common shares and common sharepurchase warrants in a registered direct offering. AEterna Zentaris expects toreceive net proceeds of approximately US$9.25 million after deductingplacement agent fees and other offering expenses. Under the terms of aSecurities Purchase Agreement, the Company will sell to such institutionalinvestors an aggregate of 5,319,149 common shares of its capital at a price ofUS$1.88 per share and issue warrants to acquire an aggregate of 1,861,702common shares at an exercise price of US$2.06 per share.The warrants to purchase additional common shares of AEterna Zentaris will beexercisable beginning three months after issuance and will expire 30 monthsafter issuance. All of the common shares and warrants were offered pursuant toan effective shelf registration statement. Proceeds from the transaction willbe used for general corporate purposes, including clinical development of ourleading oncology and endocrinology compounds.

The offering is expected to beconsummated no later than June 24, 2009, subject to customary closingconditions.Rodman & Renshaw, LLC, a subsidiary of Rodman & Renshaw Capital Group, Inc.,(Nasdaq: RODM ( )), acted as the exclusiveplacement agent for the transaction. The placement agent will receivethirty-month warrants, exercisable beginning six months after issuance, topurchase 287,234 common shares at US$2.35 per share.In connection with the offering, the Company will file a prospectus supplementto its existing base shelf prospectus with the Canadian securities regulatoryauthorities and with the Securities and Exchange Commission. Copies of theprospectus supplement and accompanying prospectus may be obtained directlyfrom the Company or by contacting AEterna Zentaris Inc., 1405 duParc-Technologique Boulevard, Quebec City, Canada G1P 4P5.This press release shall not constitute an offer to sell or a solicitation ofan offer to buy any securities nor shall there be any sale of such securitiesin any jurisdiction in which such offer, solicitation or sale would beunlawful prior to registration or qualification under the securities laws ofany such jurisdiction. This offering is being made by means of a prospectussupplement to the Company’s existing base prospectus that is part of its shelfregistration statement previously filed with and declared effective by theSecurities and Exchange Commission.About AEterna Zentaris Inc.AEterna Zentaris Inc.

is a global biopharmaceutical company focused onendocrine therapy and oncology, with proven expertise in drug discovery,development and commercialization. News releases and additional informationare available at StatementsThis press release contains forward-looking statements made pursuant to thesafe harbor provisions of the U.S. Securities Litigation Reform Act of 1995.Forward-looking statements involve known and unknown risks and uncertainties,which could cause the Company’s actual results to differ materially from thosein the forward-looking statements. Such risks and uncertainties include, amongothers, the availability of funds and resources to pursue R&D projects, thesuccessful and timely completion of clinical studies, the ability of theCompany to take advantage of business opportunities in the pharmaceuticalindustry, uncertainties related to the regulatory process and general changesin economic conditions.

Investors should consult the Company’s quarterly andannual filings with the Canadian and U.S. securities commissions foradditional information on risks and uncertainties relating to theforward-looking statements. Investors are cautioned not to rely on theseforward-looking statements. The Company does not undertake to update theseforward-looking statements. We disclaim any obligation to update any suchfactors or to publicly announce the result of any revisions to any of theforward-looking statements contained herein to reflect future results, eventsor developments except if we are requested by a governmental authority orapplicable law.SOURCEAETERNA ZENTARIS INC.Investor Relations: Ginette Vallieres, Investor Relations Coordinator, (418)652-8525 ext. 265, ; Media Relations: Paul Burroughs,Director of Communications, (418) 652-8525 ext.

ATENAS (AFP) – Grecia lanzó el jueves una emisión de obligaciones a diez años para captar 5.000 millones de euros (unos 6.800 millones de dólares), tras haber anunciado la víspera un nuevo ajuste draconiano para tratar de recuperar la confianza de los inversores.

The industrialend-user segment is also emerging as a significant source of retrofits, as plantowners have been investing in capacity expansions, new expansions, andrefurbishing aging power generation plants to improve productivity. Industrieshad invested substantially in brown field projects and maintenance and capacityreplacement in 2007, providing relief to gasket manufacturers. Although the economic slump is likely to defer a few industrial projects thatwere to be taken up in 2009 and 2010, the already initiated ones will go a longway in shoring up the gaskets market. The postponement of oil and gas expansionprojects will also curb the rapid growth of the market until 2010.

“Decreasingoil prices are expected to reduce capacities until 2010, but with marketstabilization, the refurbishment of existing plants becomes necessary,” says theanalyst of this research. “The aftermarket business will see the gaskets marketsgrow moderately during this period.” Acknowledging the challenge of operating inthese difficult economic environments, companies all over the world are strivingto lower operational expenditure and improve returns on investment. With manycompanies also looking to considerably downsize maintenance personnel forequipment repair or breakdown, there is a large market for products that offerbetter reliability and life cycle cost benefits. DUBLIN–(Business Wire)–Research and Markets( http://) hasannounced the addition of the “Three Case Studies in Technology Innovation(Apple, Google, Pixar)” report to their offering. This bundled report contains three innovation case studies, and focus on theinnovation efforts of Apple, Google, and Pixar. These three companies haveconsistently defined the cutting-edge in technology.

LOS ÁNGELES (AFP) – La hija del senador estadounidense y ex candidato a la presidencia John Kerry fue arrestada este jueves en Los Ángeles por conducir ebria, informó la policía. Alexandra Forbes Kerry, directora de cine y productora de 36 años, fue arrestada en Hollywood poco después de medianoche.

The KR 16will be executing dry tool paths of the waterjet process around complex 3D partswith quick change tooling ability to demonstrate milling, drilling, and materialhandling. The quick tool changing function uses KUKA`s hand teach device,allowing for automatic tool change function and enabling the user to teach atool path manually using a joystick while utilizing KUKA safe robot technology.The KR16 robotic cell demonstration was designed and supplied by FlowInternational Corporation. In a robotic cell designed and supplied by Official KUKA Robotics SystemPartner, Dyco Inc. the flexible, fast handling KR5 Sixx will be demonstratedutilizing a vision system. The vision system enables the KR5 Sixx to locate andpick random plastic bottles from a moving conveyor belt simulating loading puckcarriers.

This same solution could be used for material handling to pick randombottles and load cases. KUKA Robotics will also display a KR5 Arc in a demo cell designed and suppliedby Electro-Hydraulic Automation an Official KUKA Robotics System Partner. Thedemo cell shows the highly versatile KR5 ARC holding an air powered cutting toolto trim and cut holes in plastics parts, simulating the cuts used in vehicledashboard openings. KUKA Robotics will display an injection molding extraction cell using the KR5Sixx. The KR5 Sixx features the flexibility of variable mounting options offloor or ceiling along with fast handling capabilities, will simulate theextraction of medical syringes from an injection molding machine.

LOS ANGELES (AFP) – El actor Charlie Sheen fue acusado el lunes de atacar a su esposa Brooke Mueller tras una denuncia que involucraba a la pareja presentada en Navidad en un centro de vacaciones de Colorado (oeste).

Shares in PKN rose 2.2 percent late in the session, in linewith the wider market. The stock has gained 9.4 percent so farthis year, outperforming a 7.7 percent rise of Warsaw’s mainWIG20 index .WIG20 (Editing by David Jones). BEIJING, June 19 /PRNewswire-Asia/ — Sinovac Biotech Ltd.(NYSE Amex: SVA), a leading developer and provider of vaccines in China,announced today that the Company received the first order in China to supplyits influenza A (H1N1) vaccine to the Beijing government. The initial orderconsists of 4 million doses and is expected to be delivered by the end ofSeptember.This order will be administered to 2 million people in the highrisk group.Additional orders are expected beginning in October and, intotal,Sinovac expects to supply approximately 10 million doses to the Beijinggovernment.The 10 million doses will be administered to 5 million people inBeijing.On June 14, 2009, Sinovac completed construction of the H1N1 virus seedbank necessary to produce a virus antigen and commenced production of thefirst batch of H1N1 vaccine.Sinovac expects to complete production of thefirst batch by the end of July.Mr.

Weidong Yin, Chairman, President and CEO of Sinovac, commented, “Weare organizing and coordinating all personnel and resources to produce theH1N1 vaccine, as we have almost completed the production of our seasonalinfluenza vaccine.With the support and instruction of the relevantgovernment and health authorities, Sinovac will fully utilize its provendevelopment and production abilities from both the H5N1 vaccine and seasonalflu vaccine to ensure the efficient production of the H1N1 vaccine.We areworking closely with authorities in order to contribute to the prevention andcontrol of the H1N1 epidemic situation.”About SinovacSinovac Biotech Ltd. is a China-based biopharmaceutical company thatfocuses on the research, development, manufacture and commercialization ofvaccines that protect against human infectious diseases. Sinovac’s vaccineproducts include Healive(R) (hepatitis A), Bilive(R) (combined hepatitis A andB), and Anflu(R) (influenza). Panflu(TM), Sinovac’s pandemic influenza vaccine(H5N1), has already been approved for government stockpiling.Sinovac isdeveloping vaccines for enterovirus 71, universal pandemic influenza, Japaneseencephalitis vaccine, and human rabies vaccine.Its wholly owned subsidiary,Tangshan Yian, is conducting field trials for independently developedinactivated animal rabies vaccines.Safe Harbor StatementThis announcement contains forward-looking statements.

These statementsare made under the “safe harbor” provisions of the U.S Private SecuritiesLitigation Reform Act of 1995. These forward-looking statements can beidentified by words or phrases such as “will,” “expects,” “anticipates,”"future,” “intends,” “plans,” “believes,” “estimates” and similar statements.Among other things, the business outlook and quotations from management inthis press release contain forward-looking statements. Statements that are nothistorical facts, including statements about Sinovac’s beliefs andexpectations, are forward-looking statements. Forward-looking statementsinvolve inherent risks and uncertainties. A number of important factors couldcause actual results to differ materially from those contained in anyforward-looking statement.

BRASILIA (AFP) – Unos indígenas de la Amazonia brasileña localizaron este viernes el avión militar desaparecido la víspera, con nueve supervivientes, mientras un tripulante sigue desaparecido y hay otro atrapado entre los hierros, informó la Fuerza Aérea Brasileña (FAB).

The KR 16will be executing dry tool paths of the waterjet process around complex 3D partswith quick change tooling ability to demonstrate milling, drilling, and materialhandling. The quick tool changing function uses KUKA`s hand teach device,allowing for automatic tool change function and enabling the user to teach atool path manually using a joystick while utilizing KUKA safe robot technology.The KR16 robotic cell demonstration was designed and supplied by FlowInternational Corporation. In a robotic cell designed and supplied by Official KUKA Robotics SystemPartner, Dyco Inc. the flexible, fast handling KR5 Sixx will be demonstratedutilizing a vision system. The vision system enables the KR5 Sixx to locate andpick random plastic bottles from a moving conveyor belt simulating loading puckcarriers. This same solution could be used for material handling to pick randombottles and load cases. KUKA Robotics will also display a KR5 Arc in a demo cell designed and suppliedby Electro-Hydraulic Automation an Official KUKA Robotics System Partner.

Thedemo cell shows the highly versatile KR5 ARC holding an air powered cutting toolto trim and cut holes in plastics parts, simulating the cuts used in vehicledashboard openings. KUKA Robotics will display an injection molding extraction cell using the KR5Sixx. The KR5 Sixx features the flexibility of variable mounting options offloor or ceiling along with fast handling capabilities, will simulate theextraction of medical syringes from an injection molding machine. The KUKA Robotics System Partner network is designed to mutually benefit eachorganization`s users by extending the way customers can access tailoredsolutions from experienced system partners with the major competitive andtechnological advantage of high precision KUKA robots. The KUKA Robotics SystemPartner Network includes experienced system builders, system providers,application specialists and expert robot integrators. KUKA robots are utilized in many different facets of the robotics industry fromautomotive, aerospace, consumer goods, logistics, food, pharmaceutical, medical,foundry and plastics industries and in multiple applications including materialhandling, packaging, palletizing, welding and surface finishing. For moreinformation contact KUKA Robotics at 866-873-5852 or visit their website at.